Equity · Healthcare

APLS

Apellis Pharmaceuticals, Inc. · NGM

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for APLS to draw a line in its place.

The chart above plots the price of APLS over the range selected — one day to the full history — drawn by TradingView from their own data.

APLS insider trades

SEC Form 4

APLS has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 29 April 2026.

Date Insider Type Shares Value

11 Feb 2026 DeLong Mark Jeffrey Chief Business & Strat Officer Sell 368 $8K

22 Jan 2026 Watson David O. General Counsel Sell 7,832 $170K

22 Jan 2026 Sullivan Timothy Eugene Chief Financial Officer Sell 10,287 $224K

22 Jan 2026 Nicholson Nur Chief Technical Officer Sell 7,725 $168K

22 Jan 2026 Francois Cedric Chief Executive Officer Sell 27,192 $592K

22 Jan 2026 Deschatelets Pascal Chief Scientific Officer Sell 5,928 $129K

22 Jan 2026 DeLong Mark Jeffrey Chief Business & Strat Officer Sell 3,371 $73K

22 Jan 2026 Chopas James George VP/Chief Accounting Officer Sell 2,064 $45K

22 Jan 2026 Baumal Caroline Chief Medical Officer Sell 2,797 $61K

20 Jan 2026 Watson David O. General Counsel Sell 2,475 $49K

20 Jan 2026 Sullivan Timothy Eugene Chief Financial Officer Sell 2,892 $57K

20 Jan 2026 Nicholson Nur Chief Technical Officer Sell 2,203 $44K

Showing the 12 most recent of 44 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value

29 Apr 2026 Baumal Caroline Chief Medical Officer Gift 900

06 Apr 2026 O'Brien Stephanie Monaghan Director Other 5,750

27 Feb 2026 Dolsten Mikael Director Award 14,312

03 Feb 2026 Francois Cedric Chief Executive Officer Option exercise 8,840 $33K

28 Jan 2026 Francois Cedric Chief Executive Officer Award 195,952

28 Jan 2026 Watson David O. General Counsel Award 55,986

28 Jan 2026 Sullivan Timothy Eugene Chief Financial Officer Award 58,140

28 Jan 2026 Nicholson Nur Chief Technical Officer Award 45,220

28 Jan 2026 MELTZER LESLIE Chief Research and Development Award 45,220

28 Jan 2026 Deschatelets Pascal Chief Scientific Officer Award 25,840

28 Jan 2026 DeLong Mark Jeffrey Chief Business & Strat Officer Award 36,606

28 Jan 2026 Chopas James George VP/Chief Accounting Officer Award 16,150

Showing the 12 most recent of 31 compensation filings in this window. The figures above count all of them.

APLS insider trades

APLS institutional holders